The most common side effects of GLP-1 analogues are nausea and vomiting, which have been attributed to delayed gastric emptying [14,15,16]
This is an alarming sign for the GLP-1 industry as the impact of tariffs looms in an already uncertain market, affecting other areas of consumer spending, such as travel, for example
Doses above 2ml per injection show no additional methylation benefit in controlled trials and increase injection site discomfort without improving fat mobilisation
For instance, there are many common medications that have weight-promoting side effects
GLP-1 plays a key role in glucose control, weight loss, digestion, and cardiovascular protection
For instance, a study in 72 obese subjects demonstrated that 20 weeks on semaglutide 2.4mg/weekly caused a 35% decrease in caloric consumption during a free, unrestricted test meal when compared to placebo [13]